secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bioventus Inc. (BVS)
CIK:        0001665988
Form:       8-K
Filed at:   2022-06-21T23:59:59+00:00
Accession:  0001628280-22-017685
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Bioventus shareholders elect four Class I directors, ratify Grant Thornton as auditor for 2022
--------------------------------------------------------------------------------

- Elected Class I directors: McMurry-Heath (60,416,389 for), Neels (56,271,187), Nohra (56,281,977), Vizirgianakis (60,862,412); broker non-votes 7,070,353 each.
- Ratified Grant Thornton LLP as independent auditor for 2022 with 67,929,557 for, 89,283 against, 6,345 abstained (no broker non-votes).
- Annual Meeting had 68,025,185 shares present (88.5% of outstanding common stock).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1665988/000162828022017685/0001628280-22-017685-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1665988/000162828022017685/bvs-20220617.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-017685

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer